Skip to main content
low economyVERIFIED

Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil

Verified: 2 outlets in 2 countries have reported this story since Nov 16.

📍 New York, US·🕐 2h ago·2 outlets

NEW YORK: Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people familiar with the matter.

How sure are we

✓ Verified · 2 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

The story so far · 2 reports · · 2 countries✓ Verified Nov 16, 3:19 AM UTC
  1. Nov 16, 1:18 AM UTCFirst report· you’re reading this
    Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bilnst.com.my ↗
  2. Nov 16, 3:19 AM UTC+2 h
    J&J looks to buy Ollin Biosciences for up to $3.4 billion, FT saysinvesting.com ↗
  3. Verified: a second independent outlet reported itNov 16, 3:19 AM UTC · +2 h
Location
Verification Log1
cross checkconfirmed90%

[Claude] Report 2 covers the same FT-reported J&J deal to buy Ollin Biosciences for up to $3.4 billion, with matching details.

12m ago
Powered by WorldPulse Verification Engine
Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
87%

Very high · How we score this

Risk Score
low risk